Navigation Links
ProteinSimple Launches New System for Protein Biologics
Date:10/6/2011

SANTA CLARA, Calif., Oct. 6, 2011 /PRNewswire/ -- ProteinSimple today announced the launch of the iCE3, a next-generation platform for quality control monitoring of protein-based therapeutics. The iCE3 platform will be unveiled at the CE Pharm 2011 conference, October 9-13, 2011, at Amelia Island, FL.

Manufacturers of protein-based therapeutics must monitor product purity closely. Imaged capillary electrophoresis (iCE) systems detect subtle impurities in protein formulations, and therefore have been adopted enthusiastically by major pharmaceutical and biotechnology companies worldwide.

The new iCE3 was designed with speed and sample throughput in mind, to help researchers address the flood of new protein biologics under development. Improved system stability helps accelerate method development and method transfer. Redesigned fluid paths increase run-to-run reproducibility. New automation options increase unattended run flexibility. The iCE3 truly powers protein research.

"It can take weeks to develop methods using older analysis techniques, and up to an hour to run each sample," commented Susan Darling, Director of Product Management.  "Our customers consistently point to rapid method development as a key advantage of iCE systems, and the iCE3 raises this bar even further. Researchers get the speed, resolution and accuracy they need, even in their most challenging samples. Our ultimate goal is to help customers achieve faster drug approvals, and the iCE3 does just that."

The iCE3 is the second recent addition to ProteinSimple's family of products for biologics manufacturers. In May of this year, the MFI 5000 series of imaging analyzers was introduced to meet new regulatory requirements for monitoring aggregates and particles in protein formulations.

About ProteinSimple

ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. The Company's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins. ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein-based therapeutics and systems that provide fresh insight into protein signaling. ProteinSimple has over 180 employees, more than 10,000 systems installed around the world and is headquartered in Santa Clara, California. For more information, visit www.proteinsimple.com


'/>"/>
SOURCE ProteinSimple
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ProteinSimple Reinvents the Western Blot
2. Cell Biosciences Changes Name to ProteinSimple
3. Brainlab Launches Newest Innovation in Image Guided Surgery Technology
4. Neogen Launches Fully Quantitative Lateral Flow Test for Aflatoxin
5. MO BIO Laboratories, Inc. Launches the RTS DNase™ Kit
6. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
7. Poplar Healthcare Forms Parent Company, Launches New Web Site
8. Cellular Dynamics Launches Innovative Research Grant Program
9. Boston Scientific Launches Neuromodulation Learning Institute To Enhance Clinical Education For Spinal Cord Stimulation
10. Arthrosurface Launches Worlds First Easy Access Glenoid Resurfacing System
11. Parents Guide to Cord Blood Foundation Launches Nations First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):